Risk of Multidrug Resistant Bacteria Acquisition in Patients with Declared
Adult
Anti-Bacterial Agents
/ pharmacology
Bacteria
Carrier State
Drug Resistance, Multiple, Bacterial
/ drug effects
Female
Hospitalization
Humans
Hypersensitivity
Intensive Care Units
Male
Methicillin-Resistant Staphylococcus aureus
/ drug effects
Middle Aged
Retrospective Studies
Risk Factors
beta-Lactams
Journal
Journal of immunology research
ISSN: 2314-7156
Titre abrégé: J Immunol Res
Pays: Egypt
ID NLM: 101627166
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
11
2021
accepted:
22
12
2021
entrez:
24
1
2022
pubmed:
25
1
2022
medline:
17
3
2022
Statut:
epublish
Résumé
The risk of extended spectrum The study included all patients admitted in ICU and receiving antibiotic treatment from January 2007 to December 2018. ESBL bacterial acquisition was the main clinical outcome. Mortality in ICU, multidrug resistant bacterial carriage at admission and discharge were the secondary outcomes. Overall, 3332 patients were included, 132/3332 (3.9%) were labelled This study confirms that patients with declared
Identifiants
pubmed: 35071608
doi: 10.1155/2022/8906316
pmc: PMC8769862
doi:
Substances chimiques
Anti-Bacterial Agents
0
beta-Lactams
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8906316Informations de copyright
Copyright © 2022 Alessio Strazzulla et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Eur J Clin Microbiol Infect Dis. 2019 Nov;38(11):2163-2169
pubmed: 31372907
Int J Antimicrob Agents. 2019 Apr;53(4):416-422
pubmed: 30537533
Infect Control Hosp Epidemiol. 2018 Sep;39(9):1127-1128
pubmed: 30033886
Antimicrob Resist Infect Control. 2019 Jul 10;8:112
pubmed: 31333839
Am J Infect Control. 2020 Jun;48(6):663-667
pubmed: 31735590
JAMA. 2018 Mar 13;319(10):1024-1039
pubmed: 29536101
J Hosp Infect. 2020 Nov;106(3):419-428
pubmed: 32918969
Medicine (Baltimore). 2021 Jul 9;100(27):e26494
pubmed: 34232182
Int J Oral Maxillofac Implants. 2018 Nov/Dec;33(6):1390-1395
pubmed: 30427972
J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi57-70
pubmed: 22096067
Therapie. 2017 Feb;72(1):73-80
pubmed: 28139284
Curr Pharm Biotechnol. 2011 Dec;12(12):2062-9
pubmed: 22188438
Crit Care Resusc. 2019 Dec;21(4):265-73
pubmed: 31778633
Allergy Asthma Proc. 2014 Nov-Dec;35(6):489-94
pubmed: 25584917
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
J Antimicrob Chemother. 2013 Apr;68(4):954-9
pubmed: 23194721
Antibiotics (Basel). 2018 Aug 06;7(3):
pubmed: 30082596
BMJ. 2018 Jun 27;361:k2400
pubmed: 29950489
J Asthma Allergy. 2021 Jan 18;14:31-46
pubmed: 33500632
Eur J Clin Microbiol Infect Dis. 2021 Jul;40(7):1511-1516
pubmed: 33625621
Clin Microbiol Infect. 2014 Oct;20(10):954-62
pubmed: 25294340
Int J Antimicrob Agents. 2020 Jul;56(1):105979
pubmed: 32325203
Can J Infect Dis Med Microbiol. 2020 Sep 9;2020:2093468
pubmed: 32963653
PLoS One. 2016 Mar 16;11(3):e0150514
pubmed: 26981866
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4237-43
pubmed: 27139486